Each one in plain English, with the numbers worked through for a shareholder.
17 Oct 2025capital raising announcement▲ GoodMajor
NexGen closed its global equity raise of about A$1 billion (C$950M): 33,112,583 shares at C$12.08 in North America and 45,801,527 CDIs at A$13.10 (about A$600M) in Australia. Proceeds fund Rook I engineering, pre-production capital and general purposes.
What it means for a shareholder
33.1m new shares at C$12.08 to raise about C$600m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Final Australian-side prospectus dated 9 October for 45,801,527 shares at C$12.08, about C$553.0M, settled as CDIs. It finalises the already-announced upsized raise; no new terms.
What it means for a shareholder
45.8m new shares at C$12.08 to raise about C$553m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Final North American prospectus dated 9 October for 33,112,583 shares at C$12.08, C$400M, alongside the C$553.0M Australian CDI offering. It finalises already-announced terms and clears the way for closing, expected about 15 October.
What it means for a shareholder
33.1m new shares at C$12.08 to raise about C$400m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Canadian securities regulators issued receipts for the 9 October final prospectus, with expert consents from SLR, Wood and others for the Arrow technical report. Procedural step clearing the October raise for closing; no new terms.
Amended draft prospectus for the Australian CDI offering now shows 45,801,527 shares at C$12.08, about C$553.0M, reflecting the upsize from the earlier A$400M. Still a preliminary filing; no new terms beyond the same-day upsizing announcement.
What it means for a shareholder
45.8m new shares at C$12.08 to raise about C$553m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
The Australian part of the raise was upsized to 45,801,527 shares at A$13.10 for about A$600M (from A$400M), and the bookbuild has closed. With the C$400M North American bought deal at C$12.08, it lifts the total raise; closing expected about 15 October.
What it means for a shareholder
45.8m new shares at A$13.10 to raise about A$600m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Amended draft North American prospectus confirms 33,112,583 shares at C$12.08 for C$400,000,002.64, and the upsized Australian offering of C$553.0M. It adds Stifel, JP Morgan, BMO, National Bank, RBC and Canaccord to the Merrill Lynch syndicate. Still preliminary.
What it means for a shareholder
33.1m new shares at C$12.08 to raise about C$400m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Preliminary short form prospectus for the Australian part of the October raise, with amounts and price still blank. It is a draft covering CDIs issued alongside the North American bought deal; no new terms beyond the same-day announcement.
2 Oct 2025capital raising announcement● NeutralMajor
NexGen launched a two-part equity raise at C$12.08 a share: a C$400M bought deal (33,112,583 shares) in North America and a fully underwritten A$400M offer (30,534,351 shares) in Australia. Proceeds fund Rook I engineering, pre-production capital and general purposes. Closing expected about 15 October.
Draft North American prospectus for the October raise, filed 1 October with share numbers, price and proceeds still blank. It covers the bought deal alongside the Australian CDI offering; terms were set in the same-day announcement. Superseded by the amended version.
15 May 2024capital raising announcement▲ GoodMajor
The Australian CDI placement closed: 20,161,290 shares at C$11.11 (about C$224M), as announced. Proceeds fund development, exploration and general purposes. This completes the raising flagged earlier and adds new shares to the register.
What it means for a shareholder
20.2m new shares at C$11.11 to raise about C$224m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Canadian prospectus supplement dated 7 May 2024 qualifying the placement shares: 20,161,290 at C$11.11, about C$224M, settled via ASX CDIs. Legal documentation for the already-announced raising; no new terms in the readable text.
Australian placement firmed up at A$250M: 20,161,290 new CDIs at A$12.40, a 4.83% discount to the A$13.03 last price. Not underwritten; conditional on TSX and NYSE approvals, settlement expected by 15 May 2024. The ATM program is reduced to leave about C$140M.
What it means for a shareholder
20.2m new shares at A$12.40 to raise about A$250m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
1 May 2024capital raising announcement● NeutralMajor
The Australian placement is upsized to 20,161,290 shares at C$11.11 for about C$224M, replacing the C$180M version. The ATM program is cut to C$275.925M, leaving C$140.98M available after prior sales. Closing expected around 15 May 2024.
What it means for a shareholder
20.2m new shares at C$11.11 to raise about C$224m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
1 May 2024capital raising announcement● NeutralMajor
NexGen agreed an Australian placement of 16,129,032 shares at C$11.11 for about C$180M, settled as new ASX CDIs, with Aitken Mount as lead manager. The ATM program is cut from C$500M to C$315M to make room. Closing is expected around 15 May 2024.
What it means for a shareholder
16.1m new shares at C$11.11 to raise about C$180m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
The 11 December 2023 equity distribution agreement with Virtu ITG Canada and Virtu Americas sets up the at-the-market program for up to C$500M of shares. This is the legal document behind the renewal already announced; no new terms are shown in the readable text.
Prospectus supplement dated 11 December 2023 qualifies sale of up to C$500M of common shares through Virtu agents, in Canada and the US. It is not offered in Australia. Repeats the already announced ATM renewal; no new amounts.
12 Dec 2023capital raising announcement● NeutralMajor
NexGen renewed its at-the-market share program, now up to C$500M (up from C$250M), with Virtu, running to 8 January 2026. The January 2023 agreement was terminated. Shares sell at market price, so more dilution is possible; proceeds fund development, exploration and general purposes.
ASX cleansing prospectus lodged 12 December 2023, offering one CDI at A$10.50 (raising A$10.50). It is a technical device so shares issued, such as under the ATM, can be freely resold on ASX; not a real fundraising.
Final C$500M short form base shelf prospectus dated 8 December 2023, allowing shares, warrants, units, subscription receipts and debt to be sold over 25 months. It replaces the preliminary version; no specific raising or price is set yet.
Preliminary filing dated 1 December 2023 for a new C$500M base shelf prospectus (shares, warrants, units, debt and more) over 25 months. It is not yet final, and not offered in Australia. Presumably renews the existing shelf (inference); no raising yet.
Third refresh supplementary prospectus dated 4 October 2023 restarting the quotation timing for the ASX cleansing offer. Relates to the existing C$250M at-the-market program running to 29 January 2025. Procedural; no new raising.
Canadian material change report for the 31 August 2023 US$110M, 9.0% convertible debenture financing with QRC and WHSP. Convertible at US$6.76 (C$9.15); two-thirds of interest in cash, one-third in shares. Closing is conditional on the share trade and approvals. Repeats ref 7.
NexGen signed binding term sheets for US$110M of 9.0% unsecured convertible debentures with Queen's Road Capital and Washington H. Soul Pattinson, 5-year term, convertible at US$6.76 per share (30% premium). WHSP also buys 8.7M existing shares from QRC.
Second refresh supplementary prospectus, dated 5 July 2023, restarts the quotation timing for the single cleansing CDI tied to the C$250M at-the-market program, which runs to 29 January 2025. No new raising or figures; administrative.
Prospectus supplement dated 6 January 2023 qualifying the sale of up to C$250m of common shares under the at-the-market program via Virtu agents, under the December 2022 shelf. Not offered in Australia. Repeats the announced program; no new terms visible.
Transaction-specific prospectus dated 9 January 2023 for a 'cleansing offer' of one CDI at A$7.00, raising A$7.00. It appears to be a technical filing so shares issued under the new ATM program can be on-sold in Australia; no real capital is being raised (inference).
9 Jan 2023capital raising announcement● NeutralMajor
NexGen set up a C$250m at-the-market equity program, selling new shares on the TSX and NYSE through Virtu agents at prevailing market prices, running to 29 January 2025. Proceeds would fund Rook I development, exploration and general purposes. Sales are at NexGen's discretion, so dilution is possible; none reported yet.
NexGen's amended and restated C$500m base shelf prospectus became final on 29 December 2022, extending the August 2022 shelf to Quebec and the territories for at-the-market sales. Nothing has been issued under it; not offered in Australia.
NexGen filed a draft amended C$500m base shelf prospectus, dated 22 December 2022, extending the August 2022 shelf to Quebec and the territories so it can support at-the-market share sales. Nothing has been issued under the original; not offered in Australia.
